<DOC>
	<DOCNO>NCT02029846</DOCNO>
	<brief_summary>This study pilot randomize control trial 30 elderly type 2 diabetes patient conduct MODEL Clinical Research ( MODEL ) , Research Division Bay West Endocrinology Associates Baltimore , Maryland . The investigator hypothesize compare regimen base solely traditional drug , regimen include new drug achieve glycemic target faster induce less hypoglycemia , weight gain , side effect , short run .</brief_summary>
	<brief_title>Glycemia Diabetic Elders Trial</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>Type 2 diabetic diagnose least 6 month Patients age â‰¥ 65 year older Active patient Bay West Endocrinology practice Inadequately control oral agent and/or basal insulin HbA1c 8.0 % 12 % Eligible randomization either treatment group Patients willing follow either treatment arm include regimen use one injectables Patients English Reading Level Grade 6 Patients reside home Unwilling use regimen may contain use one injection Using short act insulin prior study Using GLP1 past 10 week History hypoglycemia unawareness episode need emergency intervention Endstage renal disease Dementia Blindness Terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>